MAZE THERAPEUTICS, INC. (MAZE)

SEC filing

MAZE THERAPEUTICS, INC.

MAZE · CIK 1842295

4 · Sep 3, 2026 · President, R&D & CMO Bernstein Harold sold 16.14K shares at $26.36/share ($425.5K); exercised options for 72.28K shares

President, R&D & CMO Bernstein Harold sold 16.14K shares at $26.36/share ($425.5K); exercised options for 72.28K shares

xslF345X06/form4-09032026_080957.xml

xslF345X06/form4-09032026_080957.xmlSEC.gov

Graphics and non-inline formats (not embedded below).